141 related articles for article (PubMed ID: 34418452)
21. Levo-tetrahydropalmatine attenuates the development and expression of methamphetamine-induced locomotor sensitization and the accompanying activation of ERK in the nucleus accumbens and caudate putamen in mice.
Zhao N; Chen Y; Zhu J; Wang L; Cao G; Dang Y; Yan C; Wang J; Chen T
Neuroscience; 2014 Jan; 258():101-10. PubMed ID: 24269936
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of brain histamine metabolism by metoprine.
Hough LB; Khandelwal JK; Green JP
Biochem Pharmacol; 1986 Jan; 35(2):307-10. PubMed ID: 3942601
[TBL] [Abstract][Full Text] [Related]
23. Distinct dose-dependent effects of methamphetamine on real-time dopamine transmission in the rat nucleus accumbens and behaviors.
Bhimani RV; Vik M; Wakabayashi KT; Szalkowski C; Bass CE; Park J
J Neurochem; 2021 Aug; 158(4):865-879. PubMed ID: 34265079
[TBL] [Abstract][Full Text] [Related]
24. The role of reactive oxygen species in methamphetamine self-administration and dopamine release in the nucleus accumbens.
Jang EY; Yang CH; Hedges DM; Kim SP; Lee JY; Ekins TG; Garcia BT; Kim HY; Nelson AC; Kim NJ; Steffensen SC
Addict Biol; 2017 Sep; 22(5):1304-1315. PubMed ID: 27417190
[TBL] [Abstract][Full Text] [Related]
25. Valproate blocks high-dose methamphetamine-induced behavioral cross-sensitization to locomotion-inducing effect of dizocilpine (MK-801), but not methamphetamine.
Ito K; Abekawa T; Koyama T
Psychopharmacology (Berl); 2006 Jul; 186(4):525-33. PubMed ID: 16758239
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of methamphetamine-induced hyperlocomotion in mice by clorgyline, a monoamine oxidase-a inhibitor, through alteration of the 5-hydroxytriptamine turnover in the striatum.
Kitanaka N; Kitanaka J; Takemura M
Neuroscience; 2005; 130(2):295-308. PubMed ID: 15664686
[TBL] [Abstract][Full Text] [Related]
27. Pretreatment with nomifensine or nomifensine analogue 4-phenyl-1,2,3,4-tetrahydroisoquinoline augments methamphetamine-induced stereotypical behavior in mice.
Kitanaka J; Kitanaka N; Hall FS; Uhl GR; Asano H; Chatani R; Hayata S; Yokoyama H; Tanaka KI; Nishiyama N; Takemura M
Brain Res; 2012 Feb; 1439():15-26. PubMed ID: 22265332
[TBL] [Abstract][Full Text] [Related]
28. Pseudoginsenoside-F11 inhibits methamphetamine-induced behaviors by regulating dopaminergic and GABAergic neurons in the nucleus accumbens.
Fu K; Lin H; Miyamoto Y; Wu C; Yang J; Uno K; Nitta A
Psychopharmacology (Berl); 2016 Mar; 233(5):831-40. PubMed ID: 26621348
[TBL] [Abstract][Full Text] [Related]
29. The selective μ opioid receptor antagonist β-funaltrexamine attenuates methamphetamine-induced stereotypical biting in mice.
Kitanaka J; Kitanaka N; Hall FS; Uhl GR; Fukushima Y; Sawai T; Watabe K; Kubo H; Takahashi H; Tanaka K; Nishiyama N; Tatsuta T; Morita Y; Takemura M
Brain Res; 2013 Jul; 1522():88-98. PubMed ID: 23727404
[TBL] [Abstract][Full Text] [Related]
30. Lobeline attenuates methamphetamine-induced stereotypy in adolescent mice.
Tatsuta T; Kitanaka N; Kitanaka J; Morita Y; Takemura M
Neurochem Res; 2006 Nov; 31(11):1359-69. PubMed ID: 17053968
[TBL] [Abstract][Full Text] [Related]
31. Metoprine-induced thirst and diuresis in Wistar rats.
Lecklin A; Eriksson L; Leppäluoto J; Tarhanen J; Tuomisto L
Acta Physiol Scand; 1999 Mar; 165(3):325-33. PubMed ID: 10192183
[TBL] [Abstract][Full Text] [Related]
32. Antiamnesic effect of metoprine and of selective histamine H(1) receptor agonists in a modified mouse passive avoidance test.
Malmberg-Aiello P; Ipponi A; Bartolini A; Schunack W
Neurosci Lett; 2000 Jul; 288(1):1-4. PubMed ID: 10869801
[TBL] [Abstract][Full Text] [Related]
33. Striatal patch compartment lesions alter methamphetamine-induced behavior and immediate early gene expression in the striatum, substantia nigra and frontal cortex.
Murray RC; Gilbert YE; Logan AS; Hebbard JC; Horner KA
Brain Struct Funct; 2014 Jul; 219(4):1213-29. PubMed ID: 23625147
[TBL] [Abstract][Full Text] [Related]
34. Involvement of the sympathetic nervous system in the reversal of critical haemorrhagic hypotension by endogenous central histamine in rats.
Jochem J
Naunyn Schmiedebergs Arch Pharmacol; 2004 Apr; 369(4):418-27. PubMed ID: 14991226
[TBL] [Abstract][Full Text] [Related]
35. Roles of the histaminergic neurotransmission on methamphetamine-induced locomotor sensitization and reward: a study of receptors gene knockout mice.
Takino N; Sakurai E; Kuramasu A; Okamura N; Yanai K
Int Rev Neurobiol; 2009; 85():109-16. PubMed ID: 19607964
[TBL] [Abstract][Full Text] [Related]
36. Involvement of dopamine D3 receptor and dopamine transporter in methamphetamine-induced behavioral sensitization in tree shrews.
Huang J; Yang G; Li Z; Leung CK; Wang W; Li Y; Liu L; Shen B; He C; He Y; Zeng X; Li J
Brain Behav; 2020 Feb; 10(2):e01533. PubMed ID: 31943832
[TBL] [Abstract][Full Text] [Related]
37. Inhibitory effects of Shati/Nat8l overexpression in the medial prefrontal cortex on methamphetamine-induced conditioned place preference in mice.
Haddar M; Uno K; Azuma K; Muramatsu SI; Nitta A
Addict Biol; 2020 May; 25(3):e12749. PubMed ID: 30950164
[TBL] [Abstract][Full Text] [Related]
38. Pretreatment or Posttreatment with Aripiprazole Attenuates Methamphetamine-induced Stereotyped Behavior in Mice.
Kitanaka N; Kitanaka J; Hall FS; Kayama M; Sugimori H; Uhl GR; Takemura M
J Exp Neurosci; 2015; 9(Suppl 1):1-10. PubMed ID: 26525833
[TBL] [Abstract][Full Text] [Related]
39. The role of tissue plasminogen activator in methamphetamine-related reward and sensitization.
Nagai T; Noda Y; Ishikawa K; Miyamoto Y; Yoshimura M; Ito M; Takayanagi M; Takuma K; Yamada K; Nabeshima T
J Neurochem; 2005 Feb; 92(3):660-7. PubMed ID: 15659235
[TBL] [Abstract][Full Text] [Related]
40. Effects of monoamine oxidase inhibitors on methamphetamine-induced stereotypy in mice and rats.
Tatsuta T; Kitanaka N; Kitanaka J; Morita Y; Takemura M
Neurochem Res; 2005 Nov; 30(11):1377-85. PubMed ID: 16341934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
